47 studies found for:    "Myasthenia gravis"
Show Display Options
RSS Create an RSS feed from your search for:
"Myasthenia gravis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Mycophenolate Mofetil in Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: mycophenolate mofetil
2 Recruiting Exercise for Stable Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Other: Exercise
3 Completed
Has Results
Efficacy of Methotrexate in Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: Methotrexate;   Other: Placebo
4 Active, not recruiting Phase II Trial of Rituximab In Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: Rituximab;   Drug: Placebo
5 Terminated Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Biological: Hematopoietic Stem Cell Transplantation
6 Completed Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: Intravenous ImmuneGlobulin
7 Recruiting Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Behavioral: Physical exercise programme using a rowing machine
8 Completed FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients
Condition: Myasthenia Gravis
Interventions: Drug: tacrolimus;   Drug: placebo
9 Active, not recruiting Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
Condition: Myasthenia Gravis
Interventions: Procedure: thymectomy;   Drug: prednisone
10 Active, not recruiting Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: Prednisone - Azathioprine
11 Unknown  A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
12 Recruiting Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Biological: CV-MG01;   Biological: Placebo
13 Completed Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis
Conditions: Myositis;   Myasthenia Gravis
Intervention: Drug: Rituximab
14 Completed A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
Condition: Refractory Myasthenia Gravis
Intervention: Drug: Rituximab (Rituxan)
15 Completed Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis
Condition: Generalized Myasthenia Gravis
Interventions: Biological: GB-0998 (Intravenous immunoglobulin);   Procedure: Plasmapheresis
16 Recruiting Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis
Condition: Myasthenia Gravis, Generalized
Interventions: Drug: Placebo;   Drug: CFZ533
17 Completed Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Condition: Refractory Generalized Myasthenia Gravis
Interventions: Biological: Eculizumab;   Drug: Placebo
18 Active, not recruiting ECU-MG-302: An Extension Trial of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis
Condition: Refractory Generalized Myasthenia Gravis
Intervention: Biological: Eculizumab
19 Terminated Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: Subcutaneous immunoglobulins
20 Recruiting Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: HIZENTRA ®

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years